Australia markets closed

Zydus Lifesciences Limited (ZYDUSLIFE.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
1,118.55-1.55 (-0.14%)
At close: 03:30PM IST
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Assets
Current assets
Cash
Cash and cash equivalents
4,130,000
4,878,000
6,578,000
6,652,000
-
Other short-term investments
9,667,000
7,188,000
28,232,000
4,608,000
-
Total cash
13,797,000
12,066,000
34,810,000
11,260,000
-
Net receivables
52,202,000
44,168,000
33,403,000
31,273,000
-
Inventory
34,419,000
34,133,000
37,194,000
32,362,000
-
Other current assets
175,000
186,000
48,000
28,000
-
Total current assets
115,014,000
100,164,000
122,614,000
87,160,000
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
119,966,000
113,293,000
103,285,000
99,585,000
-
Accumulated depreciation
-50,818,000
-45,026,000
-39,059,000
-36,253,000
-
Net property, plant and equipment
69,148,000
68,267,000
64,226,000
63,332,000
-
Goodwill
52,660,000
48,044,000
53,646,000
53,465,000
-
Intangible assets
26,110,000
10,905,000
11,272,000
12,363,000
-
Other long-term assets
210,000
181,000
144,000
93,000
-
Total non-current assets
177,794,000
157,400,000
155,340,000
151,687,000
-
Total assets
292,808,000
257,564,000
277,954,000
238,847,000
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
7,686,000
11,632,000
38,339,000
39,740,000
-
Accounts payable
21,267,000
21,250,000
21,378,000
22,059,000
-
Other current liabilities
396,000
510,000
345,000
241,000
-
Total current liabilities
53,419,000
55,307,000
78,394,000
78,613,000
-
Non-current liabilities
Long-term debt
0
0
3,621,000
6,095,000
-
Deferred tax liabilities
4,465,000
1,944,000
1,538,000
1,197,000
-
Deferred revenues
431,000
295,000
287,000
227,000
-
Other long-term liabilities
18,000
-
3,000
10,000
17,000
Total non-current liabilities
18,373,000
5,374,000
9,022,000
10,938,000
-
Total liabilities
71,792,000
60,681,000
87,416,000
89,551,000
-
Stockholders' equity
Common stock
1,006,000
1,012,000
1,024,000
1,024,000
-
Retained earnings
203,690,000
171,898,000
154,958,000
113,842,000
-
Total stockholders' equity
198,295,000
175,158,000
169,996,000
129,923,000
-
Total liabilities and stockholders' equity
292,808,000
257,564,000
277,954,000
238,847,000
-